Navigation Links
Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump

SUNNYVALE, Calif., April 12, 2011 /PRNewswire/ -- Asante Solutions, Inc. (Asante), a medical device company focused on diabetes care, today announced it received the CE mark for its Pearl Insulin Pump, the only insulin pump that uses a pre-filled insulin cartridge. The CE mark is a European proof of conformity that certifies the product meets EU safety, health and environmental requirements. Asante has begun discussions with potential distribution partners in Europe.

"This important regulatory milestone brings us one step closer to our goal of delivering a sensible solution to the growing but underserved insulin pump market," said Phil Hopper, Asante CEO and President. "Once available, we believe the small and sleek Pearl will be the simplest-to-operate pump on the market. The Pearl is a fully featured insulin pump addressing the imperatives of safety, reliability, and ease of use required to meet the needs of people with diabetes using intensive insulin therapy."

The Pearl Insulin Pump is designed to simplify diabetes care for the more than 500,000 people worldwide who use an insulin pump and those considering insulin pump therapy. Unlike the insulin pumps currently available, which require users to manually fill an insulin reservoir using a vial of insulin and syringe, the Pearl Insulin Pump uses a 300-unit, pre-filled insulin cartridge that simplifies the process of loading the pump and filling the infusion set by reducing the number of steps required and thereby creating a less time-consuming and more convenient process.

"The Pearl is an important evolution in the design of insulin pumps," said Dr. Anthony D. Andre, Ph.D., CPE, founder of Interface Analysis Associates and current president of the Human Factors and Ergonomics Society, who has performed a number of studies on insulin pumps and other drug delivery systems for diabetes patients. "I believe the Pearl design will reduce errors, safety risks, and user frustrations with key elements of the insulin pump interaction process and create an easy, efficient, and satisfying process for diabetes patients."

This device is not yet available for sale in the United States, pending 510(k) clearance.

About Asante Solutions, Inc.

Based in the heart of Silicon Valley, Asante Solutions, Inc. is a privately-held medical device company developing simple solutions for diabetes. The company, founded in Denmark, was previously known as M2 Medical, Inc. For more information, visit

SOURCE Asante Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedShape Solutions, Inc. Named ATDC Graduate
2. MedShape Solutions, Inc. Announces Breakthrough in ACL Reconstruction
3. Fairleigh Dickinson University Announces Partnership with Medco Health Solutions, Inc. for New School of Pharmacy
4. BL Healthcares Next Generation of Wireless Remote Healthcare Solutions, Now on Verizon Wireless 4G LTE Mobile Broadband Network
5. Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution
6. MedShape Solutions, Inc. Secures Investment From IQT to Support U.S. Intelligence Community
7. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
8. Sleep Solutions, Inc. Re-incorporates as NovaSom, Inc.
9. MedShape Solutions, Inc. Receives Industry Honors and Awards
10. I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
11. PatientSafe Solutions, Inc. Announces Management Team
Post Your Comments:
(Date:12/1/2015)... Sweden , December 1, 2015 ... Cancer Study Group (IBCSG, Bern ) and ... to be part of a state of the art trial, ... --> --> The study, ... treated with anti-hormonal therapy in combination with palbociclib, a cancer ...
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015 ... through its wholly-owned UK subsidiary Proximagen Ltd., today announced ... novel, oral small molecule inhibitor of Vascular Adhesion Protein ... in the treatment of inflammatory disease. The VAP-1 inhibitor ... --> --> Under the terms ...
(Date:11/30/2015)... Asia,s largest exhibition and conference dedicated to the Medical Device ... 22 nd April 2016. --> --> ... --> -->   --> --> ... population and the government back up, the Medical Device is one of the ... . With the aging population and the government back up, the Medical ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... , ... It’s official: Tattoo taboo is a thing of the past. One ... (a whopping one in three aged 18 to 25 is inked). As tattoos transition ... ink. In fact, RealSelf , the world’s largest community for learning and sharing ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the Field for Effective Post-Affiliation Integration ,” addresses a main “pain point” for ... deliver the anticipated results, once a deal is signed. This quick-read guidance ...
(Date:12/1/2015)... China (PRWEB) , ... December 01, 2015 , ... Nurotron ... result in its largest order to date. , The order will be from ... systems. Nurotron’s Venus Cochlear Implant System is an effective solution for children and adults ...
Breaking Medicine News(10 mins):